PRELIMINARY RESULTS OF ASTX660, A NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

Authors :: B. You
J. Zhang
Anca Prica
Francine M. Foss
Antoine Hollebecque
Danna Chan
Roberta Ferraldeschi
F. Hernandez-Llizaliturri
John Lister
Martin J. S. Dyer
Amitkumar Mehta
Monica M. Mita
Nina D. Wagner-Johnston
Felipe Samaniego
Source :: Hematological Oncology. 37:527-527
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Cancer Research
business.industry
Peptidomimetic
Cutaneous T-cell lymphoma
Antagonist
Hematology
General Medicine
medicine.disease
Peripheral T-cell lymphoma
XIAP
Oncology
Relapsed refractory
medicine
Cancer research
business

Tools